Precocious puberty and related brain conditions study
Part of Hormones & metabolism clinical trials.
This study looks at children with central precocious puberty (early puberty that starts in the brain) to see how often it's linked with other developmental issues. It compares how these children develop and respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with central precocious puberty (early puberty starting before age 8 for girls, 9 for boys).
- Treatment with a GnRH analog (a medicine that slows puberty) is planned.
- Your age when early puberty started must be between 2 and 8 for girls, or 2 and 9 for boys.
- You must be under 18 years old at enrollment.
- You and your parent or guardian must agree to follow the study for at least 12 months and sign a consent form.
- You cannot have early puberty caused by a known brain tumor or other brain lesion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes children who show signs of puberty earlier than usual. It aims to better understand early and advanced puberty by tracking children's development.
This study tests a monthly injection of leuprorelin to see if it can slow or stop early puberty in children with central precocious puberty. It may help children who start puberty too early grow at a more typical pace.
This study follows children who have signs of early puberty to learn how often it happens and what may cause it. Your child may be included if they were referred for possible precocious (too-early) puberty after age 4.
This trial tests if Chinese traditional medicine plus intradermal acupuncture can help treat early puberty (precocious puberty) in girls. It aims to slow down puberty that started too soon, avoiding the need for stronger medications.
This study tests a 3-month injection compared to a 1-month injection for children with central precocious puberty (early puberty). The goal is to see if the longer-lasting shot works just as well and is safe while helping children grow at a normal pace.
This study follows people who may have too much “androgen” (a hormone) to learn what causes it and how it changes over time. You may be followed even if the exact cause is not yet known, and your results may help doctors better understand these conditions.
Hear when a new Central Precocious Puberty (CPP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.